未登录 Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma 微管稳定剂TPI 287与贝伐单抗联合治疗成人复发性胶质母细胞瘤的1期试验 Goldlust, Samuel A.; Nabors, Louis B.; Hsu, Sigmund; Mohile, Nimish; Duic, Paul J.; Benkers, Tara; Singer, Samuel; Rao, Mayank; Cappello, Lori; Silberman, Sandra L.; Farmer, George 分享 收藏
分享 收藏
分享 收藏
The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells Zumbar, Cory T.; Usubalieva, Aisulu; King, Paul D.; Li, Xiaohui; Mifsud, Caroline S.; Dalton, Hailey M.; Sak, Muge; Urio, Sara; Bryant, William M.; McElroy, Joseph P.; Farmer, George; Lehman, Norman L. 分享 收藏
分享 收藏
分享 收藏
Interim results from a phase I/II trial of TPI 287, a novel brain penetrable antimicrotubule agent, in combination with bevacizumab for the treatment of recurrent glioblastoma Silberman, Sandra L.; Goldlust, Samuel; Nabors, L. Burt; Duic, J. Paul; Benkers, Tara; Mohile, Nimish; Picker, Donald; Singer, Samuel; Farmer, George 分享 收藏
分享 收藏